drugset / Trial / NCT01334684

Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes

NCT01334684 ↗

NaSingle-groupOpen-labelTreatment

Summary

Our general aim is to investigate whether messenger RNA (mRNA) and/or microRNA (miRNA) expression profiles in white blood cells, predict metformin monotherapy efficacy in patients with type 2 diabetes.

Timeline

Start
2011-05
Primary completion
2013-04
Completion
2013-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral